一个新的深度学习模型,用于用剂量面具预测肺癌的IMRT剂量分布
Xuezhen Feng1,2, Mingqing Wang2, Xinyan Lin3,2
1School of Nuclear Science and Technology, University of South China, Hengyang, China.
Frontiers in oncology
|September 4, 2025
概括
这项研究通过使用3D U-Net模型增强了肺癌放射治疗剂量预测. 这种方法显著提高了精度,特别是在低剂量区域,用于强度调节的放射治疗.
科学领域:
- 医学物理
- 放射治疗
- 医学的人工智能
背景情况:
- 3D U-Net模型对于放射治疗剂量预测至关重要.
- 目前的模型在肺癌IMRT中处于中低剂量区域.
- 现有的方法仅限于传统的放射治疗技术.
研究的目的:
- 为肺癌强度调节辐射疗法 (IMRT) 开发一种改进的剂量预测方法.
- 研究将剂量掩盖信息纳入3DU-NET模型的影响.
- 在各种放射治疗处方方案中提高预测准确性和稳定性.
主要方法:
- 使用常规和同时集成增强 (SIB) 放射治疗的混合数据集.
- 纳入CT图像,解剖结构和剂量掩护信息作为模型输入.
- 训练了五个3DU-Net模型,用不同数量的剂量掩盖来评估它们的影响.
主要成果:
- 包括剂量掩盖在计划目标体积 (PTV) 和风险器官 (OAR) 的预测准确度显著提高.
- 在OAR中,剂量测量指标的平均绝对误差 (MAE) 降至2%以下.
- 随着剂量增加,Voxel-wise MAE持续降低,特别是在低剂量区域,提高训练效率和稳定性.
结论:
- 提出了一种用于肺癌IMRT剂量预测的新型剂量口罩辅助方法.
- 该方法在各种临床场景和处方方案中表现出高准确性和稳定性.
- 增加剂量罩的数量逐渐提高了模型的性能和预测准确性.
更多相关视频
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
8.3K
07:53Author Spotlight: Advancing 3D Modeling for Enhanced Diagnosis and Treatment of Pulmonary Nodules in Early-Stage Lung Cancer
Published on: October 13, 2023
1.6K
相关概念视频
02:43Mouse Models of Cancer Study
4.7K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
4.7K
01:06Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
333
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
333